Markets
markets
J. Edward Moreno

Hims jumps after RFK Jr. announces FDA may loosen regulations for 12 peptides

Hims & Hers rose more than 13% on Wednesday and continued to rise in premarket trading on Thursday after Health Secretary Robert F. Kennedy Jr. said that the Food and Drug Administration could ease restrictions on 12 peptides.

The move would allow compounding pharmacies to dispense the list of peptides, which have grown in popularity but are currently only available through suppliers who sell them for research purposes.

Hims and other consumer health companies have positioned themselves to begin selling peptides after getting the FDA nod.

CEO Andrew Dudum told investors in February that the company is actively exploring expanding into “peptide therapies.” The company has a network of its own compounding pharmacies, as well as a peptide facility in California that it acquired last year.

“Our medical team believes certain peptide therapies hold meaningful potential in helping Americans live healthier lives, and we are actively exploring how to expand access in a way that will be aligned with FDA guidance and reflects our commitment to consumer safety, transparency, and clinical excellence,” Hims’ Chief Medical Officer Dr. Pat Carrol said in a statement Wednesday.

Hims rallied on the news, though the stock was still down more than 20% from the start of the year through yesterday's close, taking a massive hit after its botched rollout of a copycat Wegovy pill.

The peptide gold rush: How impending deregulation could supercharge a shadow industry

The peptide gold rush: How impending deregulation could supercharge a shadow industry

Hims and other consumer health companies have positioned themselves to begin selling peptides after getting the FDA nod.

CEO Andrew Dudum told investors in February that the company is actively exploring expanding into “peptide therapies.” The company has a network of its own compounding pharmacies, as well as a peptide facility in California that it acquired last year.

“Our medical team believes certain peptide therapies hold meaningful potential in helping Americans live healthier lives, and we are actively exploring how to expand access in a way that will be aligned with FDA guidance and reflects our commitment to consumer safety, transparency, and clinical excellence,” Hims’ Chief Medical Officer Dr. Pat Carrol said in a statement Wednesday.

Hims rallied on the news, though the stock was still down more than 20% from the start of the year through yesterday's close, taking a massive hit after its botched rollout of a copycat Wegovy pill.

More Markets

See all Markets
markets
Claire Yubin Oh & David Crowther

Allbirds traded more than JPMorgan and Exxon Mobil yesterday

After a surprising announcement that the tech-bro shoemaker would be pivoting to AI on Wednesday, shares of Allbirds were flying high — soaring nearly 600% by the end of the day in record trading volume.

This was, for many reasons, completely insane.

Flipping the BIRD

Before the latest pop, Allbirds had a miniscule market cap of some ~$22 million. Yesterday, some $3.8 billion changed hands in BIRD — with the company's market cap ending the session at a still-small $148 million.

That means that the company turned over more than 25x its market cap in trading volume. Indeed, there were no other stocks with a market cap less than $1 billion that traded more than $1 billion yesterday — something of an outlier, to say the least.

Allbirds trading volume
Sherwood News

Two of the stocks that Allbirds out-traded were none other than the world's largest bank (JPMorgan), and America's largest oil company (Exxon Mobil), which only turned over $3 billion and $2.3 billion, respectively. And those weren't even particularly low-volume days for those two corporate giants — Allbirds' insane activity was way ahead of the average of the last 120 days for each.

Sole searching

Although this was perhaps more of a meme-stock story than an AI story, those two worlds are becoming to overlap, as retail traders have bought up anything adjacent to AI — particularly in the last couple of weeks as risk-on assets have ripped higher since geopolitical risks have (seemingly) abated and indices are back to all-time highs.

Of course, we've seen this movie before: remember Algorhythm Holdings, a former karaoke maker turned AI trucking logistics company, which obliterated the freight industry only a few months ago? Then there was the Long Island Iced Tea Corp., which, naturally, got into the blockchain.

Allbirds’ latest pivot, with a “long-term vision to become a fully integrated GPU-as-a-Service (GPUaaS) and AI-native cloud solutions provider” which will be funded with its new $50 million convertible financing facility, is unlikely to concern neocloud leaders like CoreWeave, which is planning to spend $30 billion in 2026.

Luke Kawa
4h
TSMC Q1 earnings crush estimates, with chipmaker lifting full-year sales guidance thanks to “extremely robust” AI demand

Management now expects sales growth of above 30% in 2026.

View of the Tainan Science Park in Taiwan, Asia.
Matt Phillips
15h

THE
HALO
EFFECT

Tasha Matsumoto
16h
Stocks notch new closing high, buoyed by end-of-war optimism and strong bank earnings

The S&P 500 and Nasdaq 100 both notched new record closes as President Trump said the Iran war was “very close to over” and as strong earnings from Morgan Stanley and Bank of America bolstered investor sentiment.

Michael Jordan holding trophy
markets
Matt Phillips

Oracle, Microsoft power battered software stocks toward best 3-day stretch in almost a year

Software shares are rising again early Wednesday, putting the widely watched iShares Expanded Tech Software ETF on track for its best three-day stretch in almost a year.

So far this week, Oracle is up more than 20%, Microsoft is up over 9%, and both ServiceNow and Datadog have gained more than 12%.

Intuit, CrowdStrike, Autodesk, and Atlassian were also among the software shares rising Wednesday after taking lumps on worries about AI disruption earlier this year.

Why the rebound? Mean reversion is a powerful force in markets, and some of these shares could simply be enjoying an overdue snapback.

Bloomberg suggests there’s some “bottom fishing” going on, with investors finally deciding that the price for these still highly profitable, cash flow-positive companies has fallen low enough to make them a compelling bargain.

Pat Tschosik, chief thematic strategist at research firm Ned Davis, told Sherwood News that the market may have been too panicky about software stocks as a whole, slamming the shares of software companies that could survive and thrive in the AI era along with those doomed to disruption.

Determining the difference between the winners and the losers will take a look at the fundamentals of individual companies.

“Somebody who does the homework is going to make a lot of money in these stocks,” he said.

Wall Street Goes Bottom Fishing in Beaten-Down Software Stocks

Wall Street Goes Bottom Fishing in Beaten-Down Software Stocks

So far this week, Oracle is up more than 20%, Microsoft is up over 9%, and both ServiceNow and Datadog have gained more than 12%.

Intuit, CrowdStrike, Autodesk, and Atlassian were also among the software shares rising Wednesday after taking lumps on worries about AI disruption earlier this year.

Why the rebound? Mean reversion is a powerful force in markets, and some of these shares could simply be enjoying an overdue snapback.

Bloomberg suggests there’s some “bottom fishing” going on, with investors finally deciding that the price for these still highly profitable, cash flow-positive companies has fallen low enough to make them a compelling bargain.

Pat Tschosik, chief thematic strategist at research firm Ned Davis, told Sherwood News that the market may have been too panicky about software stocks as a whole, slamming the shares of software companies that could survive and thrive in the AI era along with those doomed to disruption.

Determining the difference between the winners and the losers will take a look at the fundamentals of individual companies.

“Somebody who does the homework is going to make a lot of money in these stocks,” he said.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.
©2026 Sherwood Media, LLC